Feasibility of DBS screening to identify adult patients with Pompe disease in a neuromuscular clinic population
نویسنده
چکیده
Introduction In January 2012, a program was set up to rapidly screen patients with undiagnosed muscle disorders who were referred to a neuromuscular specialist in an adult hospital. A nurse was trained to do the DBS procedure as part of a series of required laboratory tests. All individuals referred to a neuromuscular specialist, either within the context of a neuromuscular clinic or an EMG laboratory, were considered. Patients with an elevated CPK, symptoms and signs indicative of a metabolic myopathy or limb girdle myopathy or muscular dystrophy, and without an obvious diagnosis (myotonic dystrophy, dermatomyositis, oculopharyngeal muscular dystrophy, FSH dystrophy) were tested on the initial visit. Those with positive DBS testing had samples sent to Duke University for genetic testing.
منابع مشابه
T.I.1 Potential for gene therapy in DMD
(population 5.5 million). We conducted a screening program in the largest neuromuscular clinic, and respiratory center in Denmark, as we hypothesised that the condition may be overlooked. The inclusion criteria were age (over 15 years), unexplained hyper-CK-aemia and myopathy, unclassified Limb-girdle muscular dystrophy (LGMD) and unexplained, restrictive respiratory insufficiency. We went thro...
متن کاملDetection rate of Pompe disease in undiagnosed neuromuscular patients from four major centres in the UK - results of a 12 month prospective audit
Introduction This 12-month audit (conducted between 1 July 2011 to 30 June 2012) was designed following a retrospective audit in a specialist neuromuscular centre (UK) using DBS testing to identify late-onset Pompe disease. The objective was to screen all patients with an unknown diagnosis presenting with a limb girdle pattern of muscle weakness +/respiratory symptoms +/scoliosis +/rigid spine ...
متن کاملThe Search for Pompe Patients in Canada: Assessing Feasibility of a National Disease Registry to Facilitate Research.
s S46 patients will be captured. More investigation into the willingness of these clinics to participate in the CNDR is required. Some evidence exists that incorporation of Pompe disease into the registry might help to facilitate improved relationships between the genetic, metabolic, and specialty neuromuscular clinics across Canada, which may have important impacts beyond the Pompe disease aud...
متن کاملLOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population.
OBJECTIVE A multicentre observational study was aimed to assess the prevalence of late-onset Pompe disease (LOPD) in a large high-risk population, using the dried blood spot (DBS) as a main screening tool. DESIGN/METHODS 17 Italian neuromuscular centres were involved in the late-onset Pompe early diagnosis (LOPED) study. Inclusion criteria were: (1) age ≥5 years, (2) persistent hyperCKaemia a...
متن کاملEvaluation prevalence of Pompe disease in Iranian patients with myopathies of unknown etiology
BACKGROUND Pompe disease is a rare but potentially treatable metabolic disorder having an estimated worldwide incidence of one in forty thousand live births. While the introduction of enzyme replacement therapy (ERT) has considerably increased the awareness of the disease, the delay in diagnosis is still consistent and most patients go undetected. OBJECTIVE This study aimed to determine the p...
متن کامل